FY2025 · period end Dec '25 · from the 10-K filed Feb 17, 2026
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Revenue | $20.07B |
Showing the most recent 5 annual periods. Get 15 years of history on the Pro plan, or unlimited history back to 1993 plus the smart-money dataset and webhooks on Institutional.
Figures a later SEC filing revised by more than 0.5% from what was originally reported. Each diff compares the same XBRL tag across two filings, so you can open both and check it yourself.
Net Cash Provided by (Used in) Operating Activities
Q3 2017
Revised up 33.9% — reported in a 10-Q.
As first reported
$554MAs it stands now
$742MAny P/OCF built on the original filing overstated the true multiple by 25.3% — and stayed wrong from Nov 2, 2017 to Oct 29, 2018.
Net Cash Provided by (Used in) Operating Activities
FY 2016
Revised up 21.6% — reported in a 10-K.
As first reported
$972MAs it stands now
$1.2BAny P/OCF built on the original filing overstated the true multiple by 17.8% — and stayed wrong from Feb 23, 2017 to Feb 19, 2019.
Net Cash Provided by (Used in) Operating Activities
FY 2015
Revised up 15.2% — reported in a 10-K.
As first reported
$600MAs it stands now
$691MAny P/OCF built on the original filing overstated the true multiple by 13.2% — and stayed wrong from Feb 24, 2016 to Feb 20, 2018.
Net Cash Provided by (Used in) Operating Activities
Q1 2013
Revised up 14.7% — reported in a 10-Q.
As first reported
$163MAs it stands now
$187MAny P/OCF built on the original filing overstated the true multiple by 12.8% — and stayed wrong from May 7, 2013 to May 8, 2014.
Operating Income (Loss)
FY 2015
Revised up 13.5% — reported in a 10-K.
As first reported
-$327MAs it stands now
-$283MRevenues
Q2 2016
Revised down 7.0% — reported in a 10-Q.
As first reported
$2.3BAs it stands now
$2.1BAny P/S built on the original filing understated the true multiple by 7.6% — and stayed wrong from Aug 3, 2016 to Aug 3, 2017.
Restatements are detected by comparing every vintage of a fact across all of BOSTON SCIENTIFIC CORP's filings back to 1993. A revision is not by itself a sign of wrongdoing — companies re-file for many legitimate reasons. This list is not exhaustive: it shows BSX's most significant revisions, and a figure absent from it has not been certified as unrevised.
| Form | Accession ID | Report Date | Filing Date | Accepted At | Source |
|---|---|---|---|---|---|
| 8-K | 0000885725-26-000041 | May 18, 2026 | May 18, 2026 | May 18, 2026 11:15 UTC | EDGAR |
| 8-K | 0000885725-26-000042 | May 18, 2026 | May 18, 2026 | May 18, 2026 11:17 UTC | EDGAR |
| 8-K | 0000885725-26-000036 | Apr 30, 2026 | May 5, 2026 | May 5, 2026 20:47 UTC | EDGAR |
| 10-Q | 0000885725-26-000033 | Mar 31, 2026 | May 1, 2026 | May 1, 2026 10:25 UTC | EDGAR |
| 8-K | 0000885725-26-000031 | Apr 22, 2026 | Apr 22, 2026 | Apr 22, 2026 10:34 UTC | EDGAR |
| 8-K | 0000885725-26-000029 | Mar 28, 2026 | Mar 30, 2026 | Mar 30, 2026 10:14 UTC | EDGAR |
| 8-K | 0000885725-26-000017 | Feb 26, 2026 | Feb 26, 2026 | Feb 26, 2026 22:11 UTC | EDGAR |
| 8-K | 0000885725-26-000013 | Feb 18, 2026 | Feb 23, 2026 | Feb 23, 2026 21:33 UTC | EDGAR |
Direct links to SEC EDGAR. BSX has additional filings available on the SEC site.
Who is buying and selling BOSTON SCIENTIFIC CORP — insider transactions from Forms 3/4/5/144 and institutional ownership from 13F, 13D, and 13G filings, point-in-time stamped like every other fact in the library. Traders read it as a positioning signal; risk desks read it as concentration.
No published research on BSX yet.
Reports appear here as analysts publish research on this company — built with Valuein's agentic workflows, every figure pinned to its SEC filing. Be the first: run equity_research_brief on BSX and publish the result to your public profile.
Get 15 years of data
Quarterly and annual financials back to 2011 on Pro (1993 on Institutional). Point-in-time accurate with zero survivorship bias.
View plansQuery via Python SDK
Pull data into DuckDB with 3 lines of Python. Works in Jupyter notebooks, scripts, and CI pipelines.
SDK docsConnect via MCP Server
Wire Claude, Cursor, or Codex directly to live SEC data with a single Bearer token. No scraping, no glue code.
MCP docs| $14.24B |
| $12.68B |
| $11.89B |
| Gross Profit | $13.85B | $11.49B | $9.90B | $8.73B | $8.18B |
|---|
| Operating Income | $3.61B | $2.60B | $2.34B | $1.65B | $1.20B |
|---|
| Net Income | — | — | — | — | — |
|---|
| EPS (Diluted) | $1.94 | $1.25 | $1.07 | $0.45 | $0.69 |
|---|
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Total Assets | $43.67B | $39.40B | $35.14B | $32.47B | $32.23B |
| Total Liabilities | — | — | — | — | — |
| Stockholders' Equity | $24.47B | $22.00B | $19.53B | $17.57B | $16.62B |
| Cash & Equivalents | $1.97B | $0.61B | $0.86B | $1.13B | $2.17B |
| Total Debt | $11.14B | $8.97B | $8.57B | $8.91B | $8.80B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Operating Cash Flow | $4.53B | $3.44B | $2.50B | $1.53B | $1.87B |
| Capital Expenditures | $0.88B | $0.79B | $0.71B | $0.59B | $0.55B |
| Free Cash Flow | $3.66B | $2.65B | $1.79B | $0.94B | $1.32B |
| Metric | FY25Dec '25 | FY24Dec '24 | FY23Dec '23 | FY22Dec '22 | FY21Dec '21 |
|---|---|---|---|---|---|
| Gross Margin | 69.0% | 68.6% | 69.5% | 68.8% | 68.8% |
| Operating Margin | 0.2% | 0.2% | 0.2% | 0.1% | 0.1% |
| Net Margin | 0.2% | 0.2% | 0.2% | 0.2% | 0.2% |
| Return on Equity | 16.7% | 14.0% | 12.6% | 12.3% | 13.6% |
| Return on Assets | 9.3% | 7.8% | 6.9% | 6.5% | 6.9% |
| Debt / Equity | 0.46× | 0.41× | 0.44× | 0.51× | 0.53× |
